CIK 0001787306 · Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812974255
- Phone
- 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,318,251
- in 11 filings, $2.1M under 10b5-1 plans
Net −$3,318,251. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-04 | Munshi Amit Director | Grant or award | +2,021 | 4,021 | ||
| 2025-12-04 | Munshi Amit Director | Grant or award · Stock Option (right to buy) | +16,502 | 16,502 | ||
| 2025-12-04 | Munshi Amit Director | Grant or award · Stock Option (right to buy) | +6,177 | 6,177 | ||
| 2025-12-01 | Welgus Howard G. Director | Sale 10b5-1 | −10,000 | $30.21 | $302K | 79,744 |
| 2025-12-01 | Matsuda Masaru See Remarks | Sale 10b5-1 | −1,657 | $30.23 | $50K | 150,641 |
| 2025-11-24 | LIN SUE-JEAN Director | Option exercise | +18,052 | $8.63 | $156K | 44,787 |
| 2025-11-24 | LIN SUE-JEAN Director | Option exercise | +7,220 | $7.51 | $54K | 52,007 |
| 2025-11-24 | LIN SUE-JEAN Director | Sale | −25,272 | $30.78 | $778K | 26,735 |
| 2025-11-24 | LIN SUE-JEAN Director | Option exercise · Stock Option (right to buy) | −18,052 | 9,000 | ||
| 2025-11-24 | LIN SUE-JEAN Director | Option exercise · Stock Option (right to buy) | −7,220 | 5,000 | ||
| 2025-11-24 | Watanabe Todd See Remarks | Sale 10b5-1 | −48,945 | $30.36 | $1.5M | 740,537 |
| 2025-11-21 | Watanabe Todd See Remarks | Sale 10b5-1 | −1,055 | $30.00 | $32K | 793,838 |
| 2025-11-20 | Gilbert Halley E Director | Option exercise | +12,220 | $7.51 | $92K | 38,655 |
| 2025-11-20 | Gilbert Halley E Director | Sale | −16,532 | $27.55 | $455K | 22,123 |
| 2025-11-20 | Gilbert Halley E Director | Option exercise · Stock Option (right to buy) | −12,220 | 0 | ||
| 2025-11-19 | Matsuda Masaru See Remarks | Sale 10b5-1 | −989 | $27.95 | $28K | 153,037 |
| 2025-11-19 | Matsuda Masaru See Remarks | Sale 10b5-1 | −1,561 | $28.50 | $44K | 151,476 |
| 2025-11-13 | Krishnamohan Neha Director | Option exercise 10b5-1 | +27,052 | $8.63 | $233K | 50,407 |
| 2025-11-13 | Krishnamohan Neha Director | Option exercise 10b5-1 | +12,220 | $7.51 | $92K | 62,627 |
| 2025-11-13 | Krishnamohan Neha Director | Sale 10b5-1 | −39,272 | $23.19 | $911K | 23,355 |
Page 8 of 13 · 241 trades